
From Tuesday, June 22 to Saturday, June 26, customers getting a COVID-19 vaccination at Walgreens pharmacies will receive $25 in Walgreens cash rewards for in-store purchases.
Alana Hippensteele is lead editor at Pharmacy Times®, Contemporary Clinic, and Pharmacy Times Oncology Edition®. She has a master's in Critical Theory and Creative Research from Pacific Northwest College of Art and a bachelor's degree in English and Art History. She has worked as an English instructor at Temple University and held editorial positions at American Cleaning & Hygiene and Tin House.

From Tuesday, June 22 to Saturday, June 26, customers getting a COVID-19 vaccination at Walgreens pharmacies will receive $25 in Walgreens cash rewards for in-store purchases.

Positive topline results have been published from a phase 3 trial assessing the CD-19 directed CAR T cell therapy lisocabtagene maraleucel as a second-line treatment in adults with relapsed or refractory LBCL.

Phase 2 clinical trial results assessing sotorasib in previously treated patients with NSCLC showed that the drug presented a median OS of 12.5 months among 124 patients.

Home infusion within the larger ambulatory infusion setting poses specific advantages and disadvantages in relation to other available location options.

Results from part A of a phase 3 trial showed sutimlimab caused patients to experience a rapid and sustained inhibition of C1-activated hemolysis in patients with cold agglutinin disease.

Researchers observed the structure of a lethal toxin produced by certain strains of Clostridium difficile bacteria.

The Novavax COVID-19 vaccine NVX-CoV2373 demonstrated 100% protection against moderate and severe disease and 90.4% efficacy overall in a phase 3 trial.

Data from a phase 3 trial comparing acalabrutinib against ibrutinib in adults with previously treated CLL showed acalabrutinib presented with non-inferior PFS and significantly fewer events of atrial fibrillation.

Phase 3 data presented at the 2021 ASCO Annual Meeting have reinforced the long-term survival benefits and well-established safety profile of single-agent ibrutinib for patients with CLL.

The definition of oligometastatic disease has continued to be shrouded in uncertainty due to the varying assessment criteria that exist at present during trial analyses.

The medieval era was a horrible time to be alive, with all manner of unpleasant and disfiguring diseases raging the public with no known cures, leaving the hands of a king as their last hope for salvation.

Frequent prostate-specific antigen screenings may lower the risk of metastasis at the time of diagnosis and lower mortality risk from prostate cancer among younger African American men.

Launched in 2020, a diabetes pilot program resulted in a significant improvement in patient outcomes for those enrolled.

In the 18th century, Franz Friedrich Anton Mesmer introduced the healing power of animal magnetism to Europe.

Final data from a phase 3 trial assessing evolocumab in patients with HIV who have high cholesterol confirmed the safety and efficacy of the drug as a treatment.

When a patient recovering from gonorrhea was fed the powder of the kuchila molung plant, the patient quickly suffered from much more than painful urination.

Data from the phase 3 VOYAGER PAD study demonstrated that rivaroxaban at 2.5 mg twice daily in combination with aspirin at 100 mg once daily was able to reduce severe vascular events in patients with PAD.

Patient engagement programs should continually evolve in order to meet patient needs and behaviors.

The implementation of multi-gene panel testing may be a necessary part of the standard of care for all colorectal cancer patients.

Seeing the vital role of pharmacists during the pandemic has solidified many students' desire to join the profession.

The historical and cultural foundations of the use of psychedelic drugs, the failure of the war on drugs in the United States, and multiple examples of other countries successfully legalizing psychedelics without societal problems developing as a result make a clear argument for the legalization of psychedelic medicine.

Kofi Amoah, PharmD, has gained unique pharmacy and health care experience while working to help end the historic COVID-19 pandemic.

To accelerate the national COVID-19 vaccination campaign, Husson University in Bangor, Maine, has announced that it will provide training to any pharmacist, technicians, or intern.

Initial data from a phase 2 study showed that a single 50 µg dose of COVID-19 vaccines mRNA-1273 or mRNA-1273.351 given as a booster to individuals who were previously vaccinated increased their neutralizing antibody titer responses against SARS-CoV-2.

One of the first anti-obesity therapies to be introduced and marketed as a pharmaceutical was 2-4-Dinitrophenol, which entered the market around 1934.

When looking at the COVID-19 variants, it is increasingly necessary to assess them in terms of the mutations embedded in the variants themselves.

During a session at the NACDS 2021 Annual Meeting, Scott Gottlieb, MD, former commissioner of the FDA from 2017 to 2019, provided an overview of where the country is heading in its response to the COVID-19 pandemic.

The APhA has joined a federal lawsuit filed by the NCPA in January to challenge DIR fees.

An interim analysis from the phase 3 ALPINE trial comparing zanubrutinib against ibrutinib demonstrated positive results in the treatment of relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma.

Due to the success of its COVID-19 vaccination clinics hosted at sites such as churches and community centers across the country, Walgreens announced that it will now activate mobile clinics in Chicago, Illinois.